KPX Lifescience Co Ltd
KOSDAQ:114450
Balance Sheet
Balance Sheet Decomposition
KPX Lifescience Co Ltd
KPX Lifescience Co Ltd
Balance Sheet
KPX Lifescience Co Ltd
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
2 528
|
8 067
|
4 370
|
5 810
|
21 115
|
90
|
7 402
|
2 219
|
751
|
3 075
|
3 430
|
7 032
|
1 922
|
524
|
7 514
|
2 402
|
0
|
0
|
6 348
|
9 068
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2 528
|
8 067
|
4 370
|
5 810
|
21 115
|
90
|
7 402
|
2 209
|
751
|
3 075
|
3 430
|
7 032
|
1 922
|
524
|
7 514
|
2 402
|
0
|
0
|
6 348
|
9 068
|
|
| Short-Term Investments |
5 300
|
2 600
|
500
|
500
|
21 654
|
33 608
|
6 982
|
18 121
|
10 140
|
11 715
|
10 408
|
19 240
|
21 747
|
19 713
|
12 454
|
12 430
|
12 515
|
13 835
|
8 105
|
3 818
|
|
| Total Receivables |
2 781
|
3 008
|
4 793
|
9 759
|
4 774
|
6 561
|
9 391
|
7 729
|
4 536
|
4 247
|
7 447
|
8 402
|
9 279
|
3 583
|
5 667
|
2 117
|
3 661
|
3 034
|
1 582
|
5 102
|
|
| Accounts Receivables |
2 713
|
3 005
|
4 773
|
9 748
|
4 757
|
6 545
|
9 386
|
7 722
|
4 343
|
4 241
|
7 447
|
8 379
|
9 118
|
3 225
|
5 551
|
1 868
|
3 561
|
2 614
|
1 460
|
5 018
|
|
| Other Receivables |
68
|
3
|
20
|
11
|
17
|
16
|
5
|
7
|
193
|
6
|
0
|
23
|
161
|
358
|
116
|
249
|
100
|
420
|
122
|
84
|
|
| Inventory |
7 865
|
8 159
|
7 422
|
9 379
|
9 478
|
8 788
|
10 171
|
11 844
|
13 049
|
7 179
|
4 654
|
7 261
|
4 847
|
5 531
|
4 892
|
6 649
|
5 732
|
6 014
|
5 311
|
3 905
|
|
| Other Current Assets |
310
|
260
|
355
|
604
|
674
|
913
|
1 249
|
1 007
|
962
|
558
|
1 035
|
1 647
|
1 011
|
1 175
|
1 135
|
973
|
1 596
|
746
|
367
|
98
|
|
| Total Current Assets |
18 784
|
22 095
|
17 441
|
26 052
|
57 695
|
49 960
|
35 195
|
40 920
|
29 439
|
26 774
|
26 974
|
43 583
|
38 806
|
30 525
|
31 662
|
24 572
|
26 892
|
26 443
|
21 712
|
21 991
|
|
| PP&E Net |
12 394
|
11 234
|
10 321
|
9 969
|
15 073
|
20 468
|
30 709
|
29 087
|
35 616
|
33 592
|
31 332
|
29 314
|
30 263
|
34 418
|
35 079
|
35 626
|
36 846
|
27 112
|
13 256
|
13 533
|
|
| PP&E Gross |
12 394
|
11 234
|
10 321
|
9 969
|
15 073
|
20 468
|
30 709
|
29 087
|
35 616
|
33 592
|
0
|
29 314
|
0
|
34 418
|
35 079
|
35 626
|
36 846
|
27 112
|
13 256
|
13 533
|
|
| Accumulated Depreciation |
1 059
|
2 526
|
4 030
|
5 626
|
7 418
|
7 338
|
9 690
|
12 962
|
15 680
|
18 267
|
0
|
24 225
|
0
|
30 578
|
32 327
|
34 703
|
36 703
|
36 541
|
50 796
|
51 309
|
|
| Intangible Assets |
1 028
|
854
|
836
|
552
|
383
|
1 392
|
1 833
|
1 473
|
1 734
|
760
|
710
|
907
|
864
|
687
|
661
|
370
|
182
|
88
|
28
|
109
|
|
| Note Receivable |
12
|
9
|
6
|
65
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
822
|
1
|
0
|
0
|
0
|
2 361
|
2 371
|
2 059
|
5 100
|
5 055
|
8 134
|
3 230
|
3 007
|
3 000
|
3 916
|
9 912
|
7 381
|
8 758
|
8 793
|
9 170
|
|
| Other Long-Term Assets |
28
|
30
|
36
|
37
|
37
|
150
|
1 335
|
1 204
|
216
|
252
|
0
|
24
|
24
|
742
|
577
|
367
|
677
|
30
|
39
|
169
|
|
| Total Assets |
33 068
N/A
|
34 224
+3%
|
28 639
-16%
|
36 676
+28%
|
73 188
+100%
|
74 331
+2%
|
71 442
-4%
|
74 743
+5%
|
72 104
-4%
|
66 434
-8%
|
67 149
+1%
|
77 058
+15%
|
72 964
-5%
|
69 372
-5%
|
71 894
+4%
|
70 846
-1%
|
71 977
+2%
|
62 432
-13%
|
43 828
-30%
|
44 972
+3%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
859
|
1 056
|
2 222
|
3 367
|
6 168
|
2 081
|
2 272
|
2 462
|
1 671
|
868
|
731
|
3 419
|
3 133
|
1 320
|
2 538
|
2 835
|
4 114
|
824
|
731
|
3 261
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
352
|
371
|
456
|
584
|
713
|
189
|
194
|
174
|
281
|
181
|
136
|
2
|
3
|
11
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3 000
|
5 700
|
3 000
|
7 000
|
4 460
|
3 360
|
0
|
7 841
|
4 146
|
5 100
|
5 100
|
6 211
|
7 433
|
6 488
|
4 800
|
4 800
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 740
|
0
|
0
|
0
|
160
|
170
|
105
|
118
|
104
|
41
|
|
| Other Current Liabilities |
1 599
|
1 211
|
2 482
|
2 833
|
3 425
|
2 700
|
2 589
|
2 445
|
4 658
|
2 375
|
2 436
|
3 626
|
3 171
|
3 131
|
3 093
|
1 429
|
3 588
|
2 004
|
1 747
|
203
|
|
| Total Current Liabilities |
2 458
|
2 267
|
4 704
|
6 201
|
12 594
|
10 833
|
8 232
|
12 362
|
11 373
|
7 317
|
10 096
|
15 080
|
10 625
|
9 833
|
11 072
|
10 781
|
15 242
|
9 437
|
7 394
|
8 314
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7 000
|
7 000
|
0
|
0
|
0
|
0
|
0
|
31
|
58
|
18
|
29
|
531
|
|
| Deferred Income Tax |
573
|
672
|
510
|
271
|
503
|
1 237
|
1 035
|
904
|
545
|
219
|
91
|
141
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
705
|
821
|
742
|
910
|
819
|
99
|
0
|
604
|
1 071
|
368
|
66
|
173
|
214
|
428
|
465
|
663
|
380
|
338
|
452
|
379
|
|
| Total Liabilities |
3 737
N/A
|
3 760
+1%
|
5 955
+58%
|
7 382
+24%
|
13 916
+89%
|
12 169
-13%
|
9 267
-24%
|
13 870
+50%
|
19 990
+44%
|
14 904
-25%
|
10 253
-31%
|
15 395
+50%
|
10 872
-29%
|
10 261
-6%
|
11 537
+12%
|
11 475
-1%
|
15 679
+37%
|
9 793
-38%
|
7 874
-20%
|
9 224
+17%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
4 000
|
4 000
|
2 500
|
2 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
7 500
|
10 000
|
10 000
|
|
| Retained Earnings |
1 486
|
2 618
|
4 859
|
6 609
|
12 817
|
15 677
|
15 711
|
14 510
|
5 614
|
5 044
|
10 457
|
14 927
|
15 120
|
12 622
|
13 892
|
12 820
|
9 680
|
6 232
|
10 105
|
12 746
|
|
| Additional Paid In Capital |
23 845
|
23 845
|
23 845
|
20 184
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
38 956
|
36 425
|
15 025
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
281
|
0
|
0
|
0
|
96
|
162
|
49
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
366
|
2 023
|
|
| Other Equity |
0
|
0
|
8 520
|
0
|
0
|
30
|
9
|
93
|
44
|
29
|
17
|
0
|
517
|
34
|
10
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
29 331
N/A
|
30 464
+4%
|
22 684
-26%
|
29 294
+29%
|
59 273
+102%
|
62 162
+5%
|
62 175
+0%
|
60 873
-2%
|
52 115
-14%
|
51 530
-1%
|
56 897
+10%
|
61 663
+8%
|
62 092
+1%
|
59 111
-5%
|
60 358
+2%
|
59 371
-2%
|
56 298
-5%
|
52 639
-6%
|
35 954
-32%
|
35 748
-1%
|
|
| Total Liabilities & Equity |
33 068
N/A
|
34 224
+3%
|
28 639
-16%
|
36 676
+28%
|
73 188
+100%
|
74 331
+2%
|
71 442
-4%
|
74 743
+5%
|
72 104
-4%
|
66 434
-8%
|
67 149
+1%
|
77 058
+15%
|
72 964
-5%
|
69 372
-5%
|
71 894
+4%
|
70 846
-1%
|
71 977
+2%
|
62 432
-13%
|
43 828
-30%
|
44 972
+3%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
8
|
8
|
5
|
11
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
20
|
20
|
20
|
19
|
|